Navigation Links
ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
Date:11/28/2008

n the onset of various diseases.

ExonHit has a multi-component commercial strategy to capture the maximum value from its leadership in alternative splicing. The Company is already generating revenues from a new generation of microarrays, SpliceArrayTM family of products, that enable life science researchers to detect crucial disease-associated information. These products are marketed worldwide in conjunction with Agilent and Affymetrix. In the field of diagnostics, ExonHit has a major collaboration with bioMerieux to develop completely novel predictive blood-based cancer diagnostics, which could play a key role in improving the treatment of breast cancer and other major cancers.

In parallel, ExonHit is developing its own therapeutic pipeline in the field of neurodegenerative diseases and cancer. The Company has advanced drug candidates into clinical trials and is evaluating several promising pre-clinical compounds. ExonHit also has a strategic partnership with Allergan, to discover and develop new therapeutics in the areas of pain, neurological diseases and ophthalmology. This collaboration provides on-going research funding to ExonHit.

Founded in 1997, ExonHit is headquartered in Paris, France and has a U.S. facility in Gaithersburg, Maryland. The Company is listed on Alternext of Euronext Paris (ticker: ALEHT; ISIN: FR0004054427) since November 17, 2005.

This press release includes only summary information and does not purport to be comprehensive. The projections, forecast and estimates of ExonHit Therapeutics which may be contained herein are for illustrative purposes only and are based on management's current views and assumptions. Such projections, forecast and estimates involve known and unknown risks and uncertainties, as described at Section 4.2 "Facteurs de risque" (Risk Factors) of the Document de Base available on ExonHit Therapeutics' website ('/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
2. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
3. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
4. ExonHit and bioMerieux Amend Their Strategic Partnership
5. ExonHit Builds A New Organisation
6. ExonHit Therapeutics - 2007 Financial Results
7. ExonHit Appoints a New Management Board
8. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
9. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
10. Loic Maurel Joins Exonhit Therapeutics to Become CEO
11. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Vivakor, Inc. (OTC Bulletin Board: VIVK) today confirmed that ... receive the dividend of shares of common stock of ... of Directors. HealthAmerica is a private Nevada corporation ... common shares on the record date. The distribution date ...
(Date:12/3/2009)... 3 Nikon Corporation, an innovator of advanced ... a licensing agreement with Harvard University granting Nikon ... Microscopy (STORM) technology. Under the terms of the ... and market them with the N-STORM name. ...
(Date:12/3/2009)... (NYSE: IMA ), a global leader in enabling ... the merger of rapid diagnostics and health management, has declared ... Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will be ... per share equal to the quotient of (a) $3.00 divided ...
(Date:12/2/2009)... 2 Reportlinker.com announces that a new ... catalogue: ,, Neurostimulation - A Global ... ,, The world neurostimulation market stands ... population, and the resultant rise in age-related ...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
... Epeius Biotechnologies,Corporation today announced that Rexin-G has ... and Drug Administration (FDA) for the,treatment of all ... third,clinical indication for which Rexin-G has been formally ... latest approval for Rexin-G validates the,company,s remarkable strategy ...
... 8, 2008Biotech and pharmaceutical firms are developing a ... complicated drug discovery process, reports Genetic Engineering ... successful approaches rely on a combination of high-throughput ... according to an article in the July issue ...
... in nanoscale lithographic technology, used in the manufacture of ... patterns of lines over larger areas than have been ... could pave the way for next-generation computer memory and ... other devices. , The team has created lines about ...
Other Biology Technology:FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 2FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 3MIT reports finer lines for microchips 2
(Date:12/3/2009)... solar panels that repels grime and dirt? Expanded battery ... Aviv University research, just published in Nature Nanotechnology ... nano-scale level that could make these futuristic visions come ... the range of 100 nanometers (roughly one-billionth of a ...
(Date:12/3/2009)... change in warmer water, according to an intriguing new study ... , Experiments with two species of young damselfish on Australia,s ... some reef fish are either consistently timid, or consistently bold, ... water temperatures rise. , A slight lift of just one ...
(Date:12/3/2009)... A team of scientists from the U.S. Department ... the Indian Institute of Science has made a major ... in DNA that is necessary to carry out important ... 2009 edition of Nature Structural & Molecular Biology ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3HealthFitness Makes Compelling Case for Employee Health Management 51822 1HealthFitness Makes Compelling Case for Employee Health Management 51822 2Immunoassay at AACC 2009 3A Tosoh Launches AIA 2000 Automated Immunoassay Analyzer 51819 1Immunoassay at AACC 2009 3A Tosoh Launches AIA 2000 Automated Immunoassay Analyzer 51819 2St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 1St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 2St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 3St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 4
... Called granulosa cells, they surround eggs and deliver nutrients ... be successfully fertilized. , How do these handmaidens grow? ... have discovered that two proteins ?TAF4b and c-Jun ?team ... the nuclei of granulosa cells. This subset of genes, ...
... bone-marrow derived stem cells can regenerate damaged renal cells ... potential new strategy for managing this inherited kidney disease ... may be useful in repairing basement membrane matrix defects ... at Beth Israel Deaconess Medical Center (BIDMC), the findings ...
... sea experiments shows there's a constant shuffling of genetic ... they use seems to be a flood of viruses, ... Professor Sally W. Chisholm, is uncovering a challenging new ... manage to exploit changing conditions such as altered light, ...
Other Biology News:A surprising pair of proteins help make healthy eggs 2New research demonstrates bone-marrow derived stem cells can reverse genetic kidney disease 2MIT: Oceans are a major gene swap-meet for plankton 2MIT: Oceans are a major gene swap-meet for plankton 3MIT: Oceans are a major gene swap-meet for plankton 4
... Mouse monoclonal [YPF19] to Yersinia ... to detect Yersinia pestis . ... from Yersinia pestis vaccine ... This antibody recognises Y.pestis F1 capsular ...
Rabbit polyclonal to ZFP200 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGKSFNHKTNLNKHER (Human) Entrez Gene ID: 7752 Swiss Protein ID: P98182...
Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
Rabbit polyclonal to Leucyl tRNA synthetase ( Abpromise for all tested applications). Antigen: L930-H1176 denatured human recombinant LRS. Entrez Gene ID: 3926 Swiss Protein ID: Q9P2J5...
Biology Products: